Araki E , Goto A , Kondo T , Noda M , Noto H , Origasa H , Osawa H , Taguchi A , Tanizawa Y , Tobe K , Yoshioka N .

Acerini, Introduction to ISPAD Clinical Practice Consensus Guidelines 2014 Compendium. 2014, Pubmed

Acerini, Introduction to ISPAD Clinical Practice Consensus Guidelines 2014 Compendium. 2014, Pubmed
Adler, Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. 2000, Pubmed
Afkarian, Kidney disease and increased mortality risk in type 2 diabetes. 2013, Pubmed
Ahmadi-Abhari, Dietary intake of carbohydrates and risk of type 2 diabetes: the European Prospective Investigation into Cancer-Norfolk study. 2014, Pubmed
Allemann, Fibrates in the prevention of cardiovascular disease in patients with type 2 diabetes mellitus: meta-analysis of randomised controlled trials. 2006, Pubmed
Alwan, Treatments for gestational diabetes. 2009, Pubmed
American Diabetes Association, 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2018. 2018, Pubmed
American Diabetes Association, 4. Lifestyle Management: Standards of Medical Care in Diabetes-2018. 2018, Pubmed
American Diabetes Association, 14. Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes-2019. 2019, Pubmed
Aoki, Fixed-dose combination of alogliptin/pioglitazone improves glycemic control in Japanese patients with type 2 diabetes mellitus independent of body mass index. 2017, Pubmed
Araki, Japanese Clinical Practice Guideline for Diabetes 2019. 2020, Pubmed
Armstrong, The impact and outcomes of establishing an integrated interdisciplinary surgical team to care for the diabetic foot. 2012, Pubmed
Aune, Physical activity and the risk of type 2 diabetes: a systematic review and dose-response meta-analysis. 2015, Pubmed
Avery, Changing physical activity behavior in type 2 diabetes: a systematic review and meta-analysis of behavioral interventions. 2012, Pubmed
Avilés-Santa, Effects of metformin in patients with poorly controlled, insulin-treated type 2 diabetes mellitus. A randomized, double-blind, placebo-controlled trial. 1999, Pubmed
Baba, Nifedipine and enalapril equally reduce the progression of nephropathy in hypertensive type 2 diabetics. 2001, Pubmed
Baigent, The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial. 2011, Pubmed
Barone, Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis. 2008, Pubmed
Barone, Postoperative mortality in cancer patients with preexisting diabetes: systematic review and meta-analysis. 2010, Pubmed
Bazzano, Intake of fruit, vegetables, and fruit juices and risk of diabetes in women. 2008, Pubmed
Beck, Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial. 2017, Pubmed
Bellamy, Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. 2009, Pubmed
Bennett, 2011, Pubmed
Berl, Cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial of patients with type 2 diabetes and overt nephropathy. 2003, Pubmed
Bhat, Effect of pioglitazone therapy in lean type 1 diabetes mellitus. 2007, Pubmed
Bhupathiraju, Glycemic index, glycemic load, and risk of type 2 diabetes: results from 3 large US cohorts and an updated meta-analysis. 2014, Pubmed
Biswas, Sedentary time and its association with risk for disease incidence, mortality, and hospitalization in adults: a systematic review and meta-analysis. 2015, Pubmed
Bjerregaard, Change in Overweight from Childhood to Early Adulthood and Risk of Type 2 Diabetes. 2018, Pubmed
Bolinder, Dapagliflozin maintains glycaemic control while reducing weight and body fat mass over 2 years in patients with type 2 diabetes mellitus inadequately controlled on metformin. 2014, Pubmed
Bolinder, Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial. 2016, Pubmed
Boniol, Physical activity and change in fasting glucose and HbA1c: a quantitative meta-analysis of randomized trials. 2017, Pubmed
Bonner, Type 2 diabetes-related foot care knowledge and foot self-care practice interventions in the United States: a systematic review of the literature. 2016, Pubmed
Booth, Incidence of type 2 diabetes after bariatric surgery: population-based matched cohort study. 2014, Pubmed
Boulton, Diabetic neuropathies: a statement by the American Diabetes Association. 2005, Pubmed
Boulé, Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta-analysis of controlled clinical trials. 2001, Pubmed
Boulé, Meta-analysis of the effect of structured exercise training on cardiorespiratory fitness in Type 2 diabetes mellitus. 2003, Pubmed
Brink, ISPAD Clinical Practice Consensus Guidelines 2014. Sick day management in children and adolescents with diabetes. 2014, Pubmed
Brown, Exercise for pregnant women with gestational diabetes for improving maternal and fetal outcomes. 2017, Pubmed
Brownrigg, The association of ulceration of the foot with cardiovascular and all-cause mortality in patients with diabetes: a meta-analysis. 2012, Pubmed
Brugts, The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials. 2009, Pubmed
Burgess, Incidence and predictors of silent myocardial infarction in type 2 diabetes and the effect of fenofibrate: an analysis from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. 2010, Pubmed
Cannon, Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes. 2015, Pubmed , Echinobase
Cappuccio, Quantity and quality of sleep and incidence of type 2 diabetes: a systematic review and meta-analysis. 2010, Pubmed
Casas, Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis. 2005, Pubmed
Chan, Long-term effects of angiotensin-converting enzyme inhibition and metabolic control in hypertensive type 2 diabetic patients. 2000, Pubmed
Chang, The effectiveness and risks of bariatric surgery: an updated systematic review and meta-analysis, 2003-2012. 2014, Pubmed
Charles, Low peripheral nerve conduction velocities and amplitudes are strongly related to diabetic microvascular complications in type 1 diabetes: the EURODIAB Prospective Complications Study. 2010, Pubmed
Charpentier, Improved glycaemic control by addition of glimepiride to metformin monotherapy in type 2 diabetic patients. 2001, Pubmed
Chen, Effect of lifestyle intervention in patients with type 2 diabetes: a meta-analysis. 2015, Pubmed
Cheung, Diabetic retinopathy and the risk of coronary heart disease: the Atherosclerosis Risk in Communities Study. 2007, Pubmed
Cheung, Is diabetic retinopathy an independent risk factor for ischemic stroke? 2007, Pubmed
Chew, Psychological interventions for diabetes-related distress in adults with type 2 diabetes mellitus. 2017, Pubmed
Chew, Effects of medical therapies on retinopathy progression in type 2 diabetes. 2010, Pubmed
Chiasson, Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. 2002, Pubmed
Chiu, Deriving ethnic-specific BMI cutoff points for assessing diabetes risk. 2011, Pubmed
Christine, Longitudinal Associations Between Neighborhood Physical and Social Environments and Incident Type 2 Diabetes Mellitus: The Multi-Ethnic Study of Atherosclerosis (MESA). 2015, Pubmed
Chudyk, Effects of exercise on cardiovascular risk factors in type 2 diabetes: a meta-analysis. 2011, Pubmed
Clair, The Effect of Cigarette Smoking on Diabetic Peripheral Neuropathy: A Systematic Review and Meta-Analysis. 2015, Pubmed
Colberg, Physical Activity/Exercise and Diabetes: A Position Statement of the American Diabetes Association. 2016, Pubmed
Colberg, Exercise and type 2 diabetes: the American College of Sports Medicine and the American Diabetes Association: joint position statement. 2010, Pubmed
Colhoun, Hospitalised hip fracture risk with rosiglitazone and pioglitazone use compared with other glucose-lowering drugs. 2012, Pubmed
Colhoun, Effects of atorvastatin on kidney outcomes and cardiovascular disease in patients with diabetes: an analysis from the Collaborative Atorvastatin Diabetes Study (CARDS). 2009, Pubmed
Collins, MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. 2003, Pubmed
Cradock, Behaviour change techniques targeting both diet and physical activity in type 2 diabetes: A systematic review and meta-analysis. 2017, Pubmed
Craig, ISPAD Clinical Practice Consensus Guidelines 2014. Definition, epidemiology, and classification of diabetes in children and adolescents. 2014, Pubmed
Davies, Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). 2018, Pubmed
Davis, Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study. 2011, Pubmed
DeFronzo, Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes. 2005, Pubmed
DeFronzo, Pioglitazone for diabetes prevention in impaired glucose tolerance. 2011, Pubmed
Delamater, ISPAD Clinical Practice Consensus Guidelines 2014. Psychological care of children and adolescents with type 1 diabetes. 2014, Pubmed
Demmer, Periodontal disease and incident type 2 diabetes: results from the First National Health and Nutrition Examination Survey and its epidemiologic follow-up study. 2008, Pubmed
Derosa, Metabolic effect of repaglinide or acarbose when added to a double oral antidiabetic treatment with sulphonylureas and metformin: a double-blind, cross-over, clinical trial. 2009, Pubmed
Diabetes Prevention Program Research Group, Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study. 2015, Pubmed
Doi, Two risk score models for predicting incident Type 2 diabetes in Japan. 2012, Pubmed
Duckworth, Glucose control and vascular complications in veterans with type 2 diabetes. 2009, Pubmed
Duke, Individual patient education for people with type 2 diabetes mellitus. 2009, Pubmed
Einhorn, Pioglitazone hydrochloride in combination with metformin in the treatment of type 2 diabetes mellitus: a randomized, placebo-controlled study. The Pioglitazone 027 Study Group. 2000, Pubmed
Ekbom, Pregnancy outcome in type 1 diabetic women with microalbuminuria. 2001, Pubmed
Elliott, Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis. 2007, Pubmed
Emadian, The effect of macronutrients on glycaemic control: a systematic review of dietary randomised controlled trials in overweight and obese adults with type 2 diabetes in which there was no difference in weight loss between treatment groups. 2015, Pubmed
Emdin, Blood pressure lowering in type 2 diabetes: a systematic review and meta-analysis. 2015, Pubmed
Eng, Glucagon-like peptide-1 receptor agonist and basal insulin combination treatment for the management of type 2 diabetes: a systematic review and meta-analysis. 2014, Pubmed
Engebretson, Evidence that periodontal treatment improves diabetes outcomes: a systematic review and meta-analysis. 2013, Pubmed
Esposito, Effects of a Mediterranean-style diet on the need for antihyperglycemic drug therapy in patients with newly diagnosed type 2 diabetes: a randomized trial. 2009, Pubmed
Esposito, A journey into a Mediterranean diet and type 2 diabetes: a systematic review with meta-analyses. 2015, Pubmed
Estacio, The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension. 1998, Pubmed
Evans, Laser photocoagulation for proliferative diabetic retinopathy. 2014, Pubmed
Examination Committee of Criteria for 'Obesity Disease' in Japan, New criteria for 'obesity disease' in Japan. 2002, Pubmed
Fang, Dose-Response Relationship between Dietary Magnesium Intake and Risk of Type 2 Diabetes Mellitus: A Systematic Review and Meta-Regression Analysis of Prospective Cohort Studies. 2016, Pubmed
Feinglos, Combination insulin and sulfonylurea therapy in insulin-requiring type 2 diabetes mellitus. 1998, Pubmed
Ferrie, Job insecurity and risk of diabetes: a meta-analysis of individual participant data. 2016, Pubmed
Figueira, Association between physical activity advice only or structured exercise training with blood pressure levels in patients with type 2 diabetes: a systematic review and meta-analysis. 2014, Pubmed
Finfer, Intensive versus conventional glucose control in critically ill patients. 2009, Pubmed
Fisher, Diabetes distress in adults with type 1 diabetes: Prevalence, incidence and change over time. 2016, Pubmed
Franz, Lifestyle weight-loss intervention outcomes in overweight and obese adults with type 2 diabetes: a systematic review and meta-analysis of randomized clinical trials. 2015, Pubmed
Freeman, Efficacy, safety, and tolerability of pregabalin treatment for painful diabetic peripheral neuropathy: findings from seven randomized, controlled trials across a range of doses. 2008, Pubmed
Frykberg, Diabetic foot disorders. A clinical practice guideline (2006 revision). 2006, Pubmed
Fu, Effectiveness of advanced carbohydrate counting in type 1 diabetes mellitus: a systematic review and meta-analysis. 2016, Pubmed
Gaede, Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. 2003, Pubmed
Gaede, Effect of a multifactorial intervention on mortality in type 2 diabetes. 2008, Pubmed
Gerstein, Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial. 2019, Pubmed
Gerstein, Long-term effects of intensive glucose lowering on cardiovascular outcomes. 2011, Pubmed
Gerstein, Diabetic retinopathy, its progression, and incident cardiovascular events in the ACCORD trial. 2013, Pubmed
Gerstein, Basal insulin and cardiovascular and other outcomes in dysglycemia. 2012, Pubmed
Ginsberg, Effects of combination lipid therapy in type 2 diabetes mellitus. 2010, Pubmed
Giovannucci, Diabetes and cancer: a consensus report. 2010, Pubmed
Giugliano, Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus: Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial). 2018, Pubmed
Gong, Morbidity and mortality after lifestyle intervention for people with impaired glucose tolerance: 30-year results of the Da Qing Diabetes Prevention Outcome Study. 2019, Pubmed
Goto, Report of the Japan Diabetes Society (JDS)/Japanese Cancer Association (JCA) Joint Committee on Diabetes and Cancer, Second Report. 2016, Pubmed
Graziani, A systematic review and meta-analysis of epidemiologic observational evidence on the effect of periodontitis on diabetes An update of the EFP-AAP review. 2018, Pubmed
Green, Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes. 2015, Pubmed
Greenwood, Glycemic index, glycemic load, carbohydrates, and type 2 diabetes: systematic review and dose-response meta-analysis of prospective studies. 2013, Pubmed
Gregg, Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: a post-hoc analysis of the Look AHEAD randomised clinical trial. 2016, Pubmed
Griffin, Universal vs. risk factor-based screening for gestational diabetes mellitus: detection rates, gestation at diagnosis and outcome. 2000, Pubmed
Grøntved, Muscle-strengthening and conditioning activities and risk of type 2 diabetes: a prospective study in two cohorts of US women. 2014, Pubmed
Grøntved, A prospective study of weight training and risk of type 2 diabetes mellitus in men. 2012, Pubmed
Grøntved, Television viewing and risk of type 2 diabetes, cardiovascular disease, and all-cause mortality: a meta-analysis. 2011, Pubmed
Guasch-Ferré, Total and subtypes of dietary fat intake and risk of type 2 diabetes mellitus in the Prevención con Dieta Mediterránea (PREDIMED) study. 2017, Pubmed
Guo, The association between daytime napping and risk of diabetes: a systematic review and meta-analysis of observational studies. 2017, Pubmed
Gæde, Years of life gained by multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: 21 years follow-up on the Steno-2 randomised trial. 2016, Pubmed
Haak, Flash Glucose-Sensing Technology as a Replacement for Blood Glucose Monitoring for the Management of Insulin-Treated Type 2 Diabetes: a Multicenter, Open-Label Randomized Controlled Trial. 2017, Pubmed
Halbesma, High protein intake associates with cardiovascular events but not with loss of renal function. 2009, Pubmed
Haneda, Antiproteinuric effect of candesartan cilexetil in Japanese subjects with type 2 diabetes and nephropathy. 2004, Pubmed
Hansen, Effect of dietary protein restriction on prognosis in patients with diabetic nephropathy. 2002, Pubmed
Harding, Dietary fat and the risk of clinical type 2 diabetes: the European prospective investigation of Cancer-Norfolk study. 2004, Pubmed
Hartweg, Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus. 2008, Pubmed
Hasan, A systematic review and meta-analysis of glycemic control for the prevention of diabetic foot syndrome. 2016, Pubmed
Hata, Magnesium intake decreases Type 2 diabetes risk through the improvement of insulin resistance and inflammation: the Hisayama Study. 2013, Pubmed
Hayashi, Minimum waist and visceral fat values for identifying Japanese Americans at risk for the metabolic syndrome. 2007, Pubmed
Hayashino, Effects of supervised exercise on lipid profiles and blood pressure control in people with type 2 diabetes mellitus: a meta-analysis of randomized controlled trials. 2012, Pubmed
He, Diabetes self-management education reduces risk of all-cause mortality in type 2 diabetes patients: a systematic review and meta-analysis. 2017, Pubmed
Heianza, Development of a new scoring system for predicting the 5 year incidence of type 2 diabetes in Japan: the Toranomon Hospital Health Management Center Study 6 (TOPICS 6). 2012, Pubmed
Heilbronn, Effect of energy restriction, weight loss, and diet composition on plasma lipids and glucose in patients with type 2 diabetes. 1999, Pubmed
Hering, Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes. 2005, Pubmed
Hermansen, Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin. 2007, Pubmed
Hessler, Diabetes distress is linked with worsening diabetes management over time in adults with Type 1 diabetes. 2017, Pubmed
Hiuge-Shimizu, Absolute value of visceral fat area measured on computed tomography scans and obesity-related cardiovascular risk factors in large-scale Japanese general population (the VACATION-J study). 2012, Pubmed
Hodge, Plasma phospholipid and dietary fatty acids as predictors of type 2 diabetes: interpreting the role of linoleic acid. 2007, Pubmed
Hogg, Measures of health-related quality of life in diabetes-related foot disease: a systematic review. 2012, Pubmed
Holman, Addition of biphasic, prandial, or basal insulin to oral therapy in type 2 diabetes. 2007, Pubmed
Holman, 10-year follow-up of intensive glucose control in type 2 diabetes. 2008, Pubmed
Home, Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial. 2009, Pubmed
Horio, GFR estimation using standardized serum cystatin C in Japan. 2013, Pubmed
Hothersall, Contemporary risk of hip fracture in type 1 and type 2 diabetes: a national registry study from Scotland. 2014, Pubmed
Hsu, BMI cut points to identify at-risk Asian Americans for type 2 diabetes screening. 2015, Pubmed
Huang, Efficacy of lifestyle interventions in patients with type 2 diabetes: A systematic review and meta-analysis. 2016, Pubmed
Huang, Prospective randomized controlled trial to evaluate effectiveness of registered dietitian-led diabetes management on glycemic and diet control in a primary care setting in Taiwan. 2010, Pubmed
Huang, Collaborative care for patients with depression and diabetes mellitus: a systematic review and meta-analysis. 2013, Pubmed
Imamura, Consumption of sugar sweetened beverages, artificially sweetened beverages, and fruit juice and incidence of type 2 diabetes: systematic review, meta-analysis, and estimation of population attributable fraction. 2015, Pubmed
Inoue, Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan. 2006, Pubmed
Ismail, Systematic review and meta-analysis of randomised controlled trials of psychological interventions to improve glycaemic control in patients with type 2 diabetes. 2004, Pubmed
Ismail, A cohort study of people with diabetes and their first foot ulcer: the role of depression on mortality. 2007, Pubmed
Ismail-Beigi, Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. 2010, Pubmed
Jaiswal, Prevalence of and Risk Factors for Diabetic Peripheral Neuropathy in Youth With Type 1 and Type 2 Diabetes: SEARCH for Diabetes in Youth Study. 2017, Pubmed
Janghorbani, Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture. 2007, Pubmed
Jensen, Peri-conceptional A1C and risk of serious adverse pregnancy outcome in 933 women with type 1 diabetes. 2009, Pubmed
Jones, Effect of metformin in pediatric patients with type 2 diabetes: a randomized controlled trial. 2002, Pubmed
Joshi, Infections in patients with diabetes mellitus. 1999, Pubmed
Juntti-Berggren, Influence of acarbose on post-prandial insulin requirements in patients with Type 1 diabetes. 2000, Pubmed
Kadowaki, Efficacy and safety of teneligliptin added to glimepiride in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled study with an open-label, long-term extension. 2014, Pubmed
Kadowaki, Efficacy and safety of canagliflozin as add-on therapy to teneligliptin in Japanese patients with type 2 diabetes mellitus: Results of a 24-week, randomized, double-blind, placebo-controlled trial. 2017, Pubmed
Kaku, Improved glycaemic control with minimal hypoglycaemia and no weight change with the once-daily human glucagon-like peptide-1 analogue liraglutide as add-on to sulphonylurea in Japanese patients with type 2 diabetes. 2010, Pubmed
Kaku, Randomized, double-blind, phase III study to evaluate the efficacy and safety of once-daily treatment with alogliptin and metformin hydrochloride in Japanese patients with type 2 diabetes. 2017, Pubmed
Kaku, Long-term Effects of Mitiglinide in Japanese Diabetics Inadequately Controlled with DPP-4 Inhibitor or Biguanide Monotherapy. 2014, Pubmed
Kashihara, Criteria of waist circumference according to computed tomography-measured visceral fat area and the clustering of cardiovascular risk factors. 2009, Pubmed
Katagiri, Effect of glycemic control on periodontitis in type 2 diabetic patients with periodontal disease. 2013, Pubmed
Katayama, Low transition rate from normo- and low microalbuminuria to proteinuria in Japanese type 2 diabetic individuals: the Japan Diabetes Complications Study (JDCS). 2011, Pubmed
Kato, Psychological factors, coffee and risk of diabetes mellitus among middle-aged Japanese: a population-based prospective study in the JPHC study cohort. 2009, Pubmed
Katon, Collaborative care for patients with depression and chronic illnesses. 2010, Pubmed
Kawahara, Reduced progression to type 2 diabetes from impaired glucose tolerance after a 2-day in-hospital diabetes educational program: the Joetsu Diabetes Prevention Trial. 2008, Pubmed
Kawamori, Voglibose for prevention of type 2 diabetes mellitus: a randomised, double-blind trial in Japanese individuals with impaired glucose tolerance. 2009, Pubmed
Kawasaki, Diagnostic criteria for acute-onset type 1 diabetes mellitus (2012): Report of the Committee of Japan Diabetes Society on the Research of Fulminant and Acute-onset Type 1 Diabetes Mellitus. 2014, Pubmed
Kawasaki, Risk of cardiovascular diseases is increased even with mild diabetic retinopathy: the Japan Diabetes Complications Study. 2013, Pubmed
Kearney, Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis. 2008, Pubmed
Keech, Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial. 2007, Pubmed
Keech, Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. 2005, Pubmed
Keegan, Effect of alendronate on bone mineral density and biochemical markers of bone turnover in type 2 diabetic women: the fracture intervention trial. 2004, Pubmed
Kelley, Effects of aerobic exercise on lipids and lipoproteins in adults with type 2 diabetes: a meta-analysis of randomized-controlled trials. 2007, Pubmed
Kendall, Effects of exenatide (exendin-4) on glycemic control over 30 weeks in patients with type 2 diabetes treated with metformin and a sulfonylurea. 2005, Pubmed
Kennedy, Does exercise improve glycaemic control in type 1 diabetes? A systematic review and meta-analysis. 2013, Pubmed
Kitabchi, Hyperglycemic crises in adult patients with diabetes. 2009, Pubmed
Kivimäki, Long working hours, socioeconomic status, and the risk of incident type 2 diabetes: a meta-analysis of published and unpublished data from 222 120 individuals. 2015, Pubmed
Klein, The Wisconsin Epidemiologic Study of Diabetic Retinopathy. IX. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is less than 30 years. 1989, Pubmed
Klein, The Wisconsin Epidemiologic Study of Diabetic Retinopathy. X. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is 30 years or more. 1989, Pubmed
Knopp, Efficacy and safety of atorvastatin in the prevention of cardiovascular end points in subjects with type 2 diabetes: the Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in non-insulin-dependent diabetes mellitus (ASPEN). 2006, Pubmed
Knott, Alcohol Consumption and the Risk of Type 2 Diabetes: A Systematic Review and Dose-Response Meta-analysis of More Than 1.9 Million Individuals From 38 Observational Studies. 2015, Pubmed
Knowler, Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. 2002, Pubmed
Kosaka, Prevention of type 2 diabetes by lifestyle intervention: a Japanese trial in IGT males. 2005, Pubmed
Kramer, Diabetic retinopathy predicts all-cause mortality and cardiovascular events in both type 1 and 2 diabetes: meta-analysis of observational studies. 2011, Pubmed
Kraut, Lactic acidosis. 2014, Pubmed
Krishnan, Reduction in diabetic amputations over 11 years in a defined U.K. population: benefits of multidisciplinary team work and continuous prospective audit. 2008, Pubmed
Kähler, Targeting intensive versus conventional glycaemic control for type 1 diabetes mellitus: a systematic review with meta-analyses and trial sequential analyses of randomised clinical trials. 2014, Pubmed
Laffel, Metformin monotherapy in youth with recent onset type 2 diabetes: experience from the prerandomization run-in phase of the TODAY study. 2012, Pubmed
Lange, ISPAD Clinical Practice Consensus Guidelines 2014. Diabetes education in children and adolescents. 2014, Pubmed
Langer, Intensified versus conventional management of gestational diabetes. 1994, Pubmed
Larsson, Diabetes mellitus and risk of colorectal cancer: a meta-analysis. 2005, Pubmed
Larsson, Diabetes mellitus and risk of bladder cancer: a meta-analysis. 2006, Pubmed
Lee, Prognostic relevance of preoperative diabetes mellitus and the degree of hyperglycemia on the outcomes of resected pancreatic ductal adenocarcinoma. 2016, Pubmed
Leiter, Lipid-altering efficacy and safety profile of combination therapy with ezetimibe/statin vs. statin monotherapy in patients with and without diabetes: an analysis of pooled data from 27 clinical trials. 2011, Pubmed
Lewis, Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. 2001, Pubmed
Li, Urinary tract and genital infections in patients with type 2 diabetes treated with sodium-glucose co-transporter 2 inhibitors: A meta-analysis of randomized controlled trials. 2017, Pubmed
Li, Diabetes and anxiety in US adults: findings from the 2006 Behavioral Risk Factor Surveillance System. 2008, Pubmed
Li, Comparative risk of new-onset diabetes mellitus for antihypertensive drugs: A network meta-analysis. 2017, Pubmed
Liebl, Comparison of insulin analogue regimens in people with type 2 diabetes mellitus in the PREFER Study: a randomized controlled trial. 2009, Pubmed
Lind, Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections: The GOLD Randomized Clinical Trial. 2017, Pubmed
Lindholm, Comparison of antihypertensive treatments in preventing cardiovascular events in elderly diabetic patients: results from the Swedish Trial in Old Patients with Hypertension-2. STOP Hypertension-2 Study Group. 2000, Pubmed
Lindholm, Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. 2002, Pubmed
Lindström, Improved lifestyle and decreased diabetes risk over 13 years: long-term follow-up of the randomised Finnish Diabetes Prevention Study (DPS). 2013, Pubmed
Lipsky, 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. 2012, Pubmed
Liu, Association between perinatal outcomes and maternal pre-pregnancy body mass index. 2016, Pubmed
Loke, Long-term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysis. 2009, Pubmed
Ludwig, The association between pregnancy weight gain and birthweight: a within-family comparison. 2010, Pubmed
Ludwig, Neighborhoods, obesity, and diabetes--a randomized social experiment. 2011, Pubmed
Lukashevich, Efficacy and safety of vildagliptin in patients with type 2 diabetes mellitus inadequately controlled with dual combination of metformin and sulphonylurea. 2014, Pubmed
Ma, Association between bone mineral density and type 2 diabetes mellitus: a meta-analysis of observational studies. 2012, Pubmed
MacLeod, Exercise lowers postprandial glucose but not fasting glucose in type 2 diabetes: a meta-analysis of studies using continuous glucose monitoring. 2013, Pubmed
Madigan, Regular self-weighing to promote weight maintenance after intentional weight loss: a quasi-randomized controlled trial. 2014, Pubmed
Makino, Prevention of transition from incipient to overt nephropathy with telmisartan in patients with type 2 diabetes. 2007, Pubmed
Malone, Prevention of amputation by diabetic education. 1989, Pubmed
Manderson, Preprandial versus postprandial blood glucose monitoring in type 1 diabetic pregnancy: a randomized controlled clinical trial. 2003, Pubmed
Marre, Equivalence of indapamide SR and enalapril on microalbuminuria reduction in hypertensive patients with type 2 diabetes: the NESTOR Study. 2004, Pubmed
Marso, Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes. 2017, Pubmed
Marso, Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes. 2016, Pubmed
Maskarinec, Diabetes incidence based on linkages with health plans: the multiethnic cohort. 2009, Pubmed
Matsuo, Revised equations for estimated GFR from serum creatinine in Japan. 2009, Pubmed
Matthews, Risks of progression of retinopathy and vision loss related to tight blood pressure control in type 2 diabetes mellitus: UKPDS 69. 2004, Pubmed
Mattoo, Metabolic effects of pioglitazone in combination with insulin in patients with type 2 diabetes mellitus whose disease is not adequately controlled with insulin therapy: results of a six-month, randomized, double-blind, prospective, multicenter, parallel-group study. 2005, Pubmed
Max, Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood. 1987, Pubmed
Meier, Use of thiazolidinediones and fracture risk. 2008, Pubmed
Melton, Fracture risk in type 2 diabetes: update of a population-based study. 2008, Pubmed
Metz, A randomized trial of improved weight loss with a prepared meal plan in overweight and obese patients: impact on cardiovascular risk reduction. 2000, Pubmed
Miller, Evidence of a strong association between frequency of self-monitoring of blood glucose and hemoglobin A1c levels in T1D exchange clinic registry participants. 2013, Pubmed
Miller, Effects of randomization to intensive glucose control on adverse events, cardiovascular disease, and mortality in older versus younger adults in the ACCORD Trial. 2014, Pubmed
Misra, Trends in yield and effects of screening intervals during 17 years of a large UK community-based diabetic retinopathy screening programme. 2009, Pubmed
Moberley, Vaccines for preventing pneumococcal infection in adults. 2013, Pubmed
Morita, Relationship between periodontal status and levels of glycated hemoglobin. 2012, Pubmed
Moriya, Diabetic retinopathy and microalbuminuria can predict macroalbuminuria and renal function decline in Japanese type 2 diabetic patients: Japan Diabetes Complications Study. 2013, Pubmed
Moses, Effect of repaglinide addition to metformin monotherapy on glycemic control in patients with type 2 diabetes. 1999, Pubmed
Muraki, Fruit consumption and risk of type 2 diabetes: results from three prospective longitudinal cohort studies. 2013, Pubmed
Murata, Intensified blood glucose monitoring improves glycemic control in stable, insulin-treated veterans with type 2 diabetes: the Diabetes Outcomes in Veterans Study (DOVES). 2003, Pubmed
Møller, A systematic review and meta-analysis of nutrition therapy compared with dietary advice in patients with type 2 diabetes. 2017, Pubmed
Nachum, Twice daily versus four times daily insulin dose regimens for diabetes in pregnancy: randomised controlled trial. 1999, Pubmed
Nakamura, Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial. 2006, Pubmed
Nakao, Role of diabetes and obesity in outcomes of the candesartan antihypertensive survival evaluation in Japan (CASE-J) trial. 2010, Pubmed
Nanri, Development of Risk Score for Predicting 3-Year Incidence of Type 2 Diabetes: Japan Epidemiology Collaboration on Occupational Health Study. 2015, Pubmed
Nathan, The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. 1993, Pubmed
Nathan, Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. 2005, Pubmed
Natovich, Cognitive Dysfunction: Part and Parcel of the Diabetic Foot. 2016, Pubmed
Nauck, Assessment of Pancreas Safety in the Development Program of Once-Weekly GLP-1 Receptor Agonist Dulaglutide. 2017, Pubmed
Neal, Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes. 2017, Pubmed
Nezu, Effect of low-protein diet on kidney function in diabetic nephropathy: meta-analysis of randomised controlled trials. 2013, Pubmed
Nishida, The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2016 (J-SSCG 2016). 2018, Pubmed
Niskanen, Reduced cardiovascular morbidity and mortality in hypertensive diabetic patients on first-line therapy with an ACE inhibitor compared with a diuretic/beta-blocker-based treatment regimen: a subanalysis of the Captopril Prevention Project. 2001, Pubmed
Nissen, Comparison of pioglitazone vs glimepiride on progression of coronary atherosclerosis in patients with type 2 diabetes: the PERISCOPE randomized controlled trial. 2008, Pubmed
Nyenwe, Evidence-based management of hyperglycemic emergencies in diabetes mellitus. 2011, Pubmed
Odden, Rethinking the association of high blood pressure with mortality in elderly adults: the impact of frailty. 2012, Pubmed
Odgers-Jewell, Effectiveness of group-based self-management education for individuals with Type 2 diabetes: a systematic review with meta-analyses and meta-regression. 2017, Pubmed
Ohkubo, Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. 1995, Pubmed
Ono, The glycemic/metabolic responses to meal tolerance tests at breakfast, lunch and dinner, and effects of the mitiglinide/voglibose fixed-dose combination on postprandial profiles in Japanese patients with type 2 diabetes mellitus. 2014, Pubmed
Ostman, Clinical outcomes to exercise training in type 1 diabetes: A systematic review and meta-analysis. 2018, Pubmed
Ozbek, Preprandial repaglinide decreases exogenous insulin requirements and HbA1c levels in type 2 diabetic patients taking intensive insulin treatment. 2006, Pubmed
Padwal, A systematic review of drug therapy to delay or prevent type 2 diabetes. 2005, Pubmed
Pai, The effectiveness of regular leisure-time physical activities on long-term glycemic control in people with type 2 diabetes: A systematic review and meta-analysis. 2016, Pubmed
Paisey, Diabetes-related major lower limb amputation incidence is strongly related to diabetic foot service provision and improves with enhancement of services: peer review of the South-West of England. 2018, Pubmed
Palmer, Comparative efficacy and safety of blood pressure-lowering agents in adults with diabetes and kidney disease: a network meta-analysis. 2015, Pubmed
Pan, Relation of active, passive, and quitting smoking with incident type 2 diabetes: a systematic review and meta-analysis. 2015, Pubmed
Patel, Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. 2008, Pubmed
Pedersen, Health effects of protein intake in healthy adults: a systematic literature review. 2013, Pubmed
Perrin, The prevalence of diabetes-specific emotional distress in people with Type 2 diabetes: a systematic review and meta-analysis. 2017, Pubmed
Pfeffer, Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome. 2015, Pubmed
Pfeffer, A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. 2009, Pubmed
Pillay, Behavioral Programs for Type 2 Diabetes Mellitus: A Systematic Review and Network Meta-analysis. 2015, Pubmed
Pillay, Behavioral Programs for Type 1 Diabetes Mellitus: A Systematic Review and Meta-analysis. 2015, Pubmed
Ponssen, Combined metformin and insulin therapy for patients with type 2 diabetes mellitus. 2000, Pubmed
Poolsup, Systematic review and meta-analysis of the effectiveness of continuous glucose monitoring (CGM) on glucose control in diabetes. 2013, Pubmed
Preiss, Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis. 2011, Pubmed
Pritchett, Duloxetine for the management of diabetic peripheral neuropathic pain: response profile. 2007, Pubmed
Pyŏrälä, Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S). 1997, Pubmed
Qiu, Impact of walking on glycemic control and other cardiovascular risk factors in type 2 diabetes: a meta-analysis. 2014, Pubmed
Rafiq, Effective treatment with oral sulfonylureas in patients with diabetes due to sulfonylurea receptor 1 (SUR1) mutations. 2008, Pubmed
Rahman, Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). 2005, Pubmed
Raskin, A randomized trial of rosiglitazone therapy in patients with inadequately controlled insulin-treated type 2 diabetes. 2001, Pubmed
Ray, Preconception care and the risk of congenital anomalies in the offspring of women with diabetes mellitus: a meta-analysis. 2001, Pubmed
Relimpio, Adding metformin versus insulin dose increase in insulin-treated but poorly controlled Type 2 diabetes mellitus: an open-label randomized trial. 1998, Pubmed
Remschmidt, Vaccines for the prevention of seasonal influenza in patients with diabetes: systematic review and meta-analysis. 2015, Pubmed
Rewers, ISPAD Clinical Practice Consensus Guidelines 2014. Assessment and monitoring of glycemic control in children and adolescents with diabetes. 2014, Pubmed
Ribaric, Diabetes and weight in comparative studies of bariatric surgery vs conventional medical therapy: a systematic review and meta-analysis. 2014, Pubmed
Rickheim, Assessment of group versus individual diabetes education: a randomized study. 2002, Pubmed
Rooke, 2011 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Peripheral Artery Disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 2011, Pubmed
Rosenstock, Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk: The CARMELINA Randomized Clinical Trial. 2019, Pubmed
Rossing, Risk factors for development of incipient and overt diabetic nephropathy in type 1 diabetic patients: a 10-year prospective observational study. 2002, Pubmed
Rotella, Depression as a risk factor for diabetes: a meta-analysis of longitudinal studies. 2013, Pubmed
Roussel, Prevention of cardiovascular disease through reduction of glycaemic exposure in type 2 diabetes: A perspective on glucose-lowering interventions. 2018, Pubmed
Rubio-Cabezas, ISPAD Clinical Practice Consensus Guidelines 2014. The diagnosis and management of monogenic diabetes in children and adolescents. 2014, Pubmed
Sabatine, Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease. 2017, Pubmed
Sabatine, Cardiovascular safety and efficacy of the PCSK9 inhibitor evolocumab in patients with and without diabetes and the effect of evolocumab on glycaemia and risk of new-onset diabetes: a prespecified analysis of the FOURIER randomised controlled trial. 2017, Pubmed
Sacks, Association between plasma triglycerides and high-density lipoprotein cholesterol and microvascular kidney disease and retinopathy in type 2 diabetes mellitus: a global case-control study in 13 countries. 2014, Pubmed
Saito, Lifestyle modification and prevention of type 2 diabetes in overweight Japanese with impaired fasting glucose levels: a randomized controlled trial. 2011, Pubmed
Saito, Islet transplantation using donors after cardiac death: report of the Japan Islet Transplantation Registry. 2010, Pubmed
Sasazuki, Diabetes mellitus and cancer risk: pooled analysis of eight cohort studies in Japan. 2013, Pubmed
Satoh, Efficacy and safety evaluation of pregabalin treatment over 52 weeks in patients with diabetic neuropathic pain extended after a double-blind placebo-controlled trial. 2011, Pubmed
Sattar, Lipid-lowering efficacy of the PCSK9 inhibitor evolocumab (AMG 145) in patients with type 2 diabetes: a meta-analysis of individual patient data. 2016, Pubmed
Sattar, Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials. 2010, Pubmed
Schauer, Bariatric surgery versus intensive medical therapy for diabetes--3-year outcomes. 2014, Pubmed
Scheen, Long-term glycaemic control with metformin-sulphonylurea-pioglitazone triple therapy in PROactive (PROactive 17). 2009, Pubmed
Schmitz, Recurrent subthreshold depression in type 2 diabetes: an important risk factor for poor health outcomes. 2014, Pubmed
Schulze, Fiber and magnesium intake and incidence of type 2 diabetes: a prospective study and meta-analysis. 2007, Pubmed
Schwartz, Effect of troglitazone in insulin-treated patients with type II diabetes mellitus. Troglitazone and Exogenous Insulin Study Group. 1998, Pubmed
Schwartz, Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome. 2018, Pubmed
Schwingshackl, Impact of different training modalities on glycaemic control and blood lipids in patients with type 2 diabetes: a systematic review and network meta-analysis. 2014, Pubmed
Scirica, Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus. 2013, Pubmed
Seaquist, Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society. 2013, Pubmed
Seino, Report of the committee on the classification and diagnostic criteria of diabetes mellitus. 2010, Pubmed
Seino, Randomized, double-blind, placebo-controlled trial of the once-daily GLP-1 receptor agonist lixisenatide in Asian patients with type 2 diabetes insufficiently controlled on basal insulin with or without a sulfonylurea (GetGoal-L-Asia). 2012, Pubmed
Selvin, Cardiovascular outcomes in trials of oral diabetes medications: a systematic review. 2008, Pubmed
Sever, Reduction in cardiovascular events with atorvastatin in 2,532 patients with type 2 diabetes: Anglo-Scandinavian Cardiac Outcomes Trial--lipid-lowering arm (ASCOT-LLA). 2005, Pubmed
Shan, Sleep duration and risk of type 2 diabetes: a meta-analysis of prospective studies. 2015, Pubmed
Shen, Efficacy of statins in patients with diabetic nephropathy: a meta-analysis of randomized controlled trials. 2016, Pubmed
Shepherd, Effect of lowering LDL cholesterol substantially below currently recommended levels in patients with coronary heart disease and diabetes: the Treating to New Targets (TNT) study. 2006, Pubmed
Shichiri, Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients. 2000, Pubmed
Shoar, Long-term and midterm outcomes of laparoscopic sleeve gastrectomy versus Roux-en-Y gastric bypass: a systematic review and meta-analysis of comparative studies. 2017, Pubmed
Siersma, Diabetic complications do not hamper improvement of health-related quality of life over the course of treatment of diabetic foot ulcers - the Eurodiale study. 2017, Pubmed
Simpson, Effect of aspirin dose on mortality and cardiovascular events in people with diabetes: a meta-analysis. 2011, Pubmed
Simpson, Treatment of periodontal disease for glycaemic control in people with diabetes mellitus. 2015, Pubmed
Sjöström, Review of the key results from the Swedish Obese Subjects (SOS) trial - a prospective controlled intervention study of bariatric surgery. 2013, Pubmed
Smith, Physical activity and incident type 2 diabetes mellitus: a systematic review and dose-response meta-analysis of prospective cohort studies. 2016, Pubmed
Snowling, Effects of different modes of exercise training on glucose control and risk factors for complications in type 2 diabetic patients: a meta-analysis. 2006, Pubmed
Sone, Serum level of triglycerides is a potent risk factor comparable to LDL cholesterol for coronary heart disease in Japanese patients with type 2 diabetes: subanalysis of the Japan Diabetes Complications Study (JDCS). 2011, Pubmed
Steinberg, Amylase, Lipase, and Acute Pancreatitis in People With Type 2 Diabetes Treated With Liraglutide: Results From the LEADER Randomized Trial. 2017, Pubmed
Storgaard, Glucagon-like peptide-1 receptor agonists and risk of acute pancreatitis in patients with type 2 diabetes. 2017, Pubmed
Stratton, Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. 2000, Pubmed
Suckling, Altered dietary salt intake for preventing and treating diabetic kidney disease. 2010, Pubmed
Taguchi, High-Dose Versus Low-Dose Pitavastatin in Japanese Patients With Stable Coronary Artery Disease (REAL-CAD): A Randomized Superiority Trial. 2018, Pubmed
Takahashi, Subgingival microflora and antibody responses against periodontal bacteria of young Japanese patients with type 1 diabetes mellitus. 2001, Pubmed
Taskinen, Safety and efficacy of linagliptin as add-on therapy to metformin in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study. 2011, Pubmed
Tatti, Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDM. 1998, Pubmed
Terauchi, Long-term safety and efficacy of tofogliflozin as add-on to insulin in patients with type 2 diabetes: Results from a 52-week, multicentre, randomized, double-blind, open-label extension, Phase 4 study in Japan (J-STEP/INS). 2018, Pubmed
Terranova, Effectiveness of lifestyle-based weight loss interventions for adults with type 2 diabetes: a systematic review and meta-analysis. 2015, Pubmed
Tesfaye, Vascular risk factors and diabetic neuropathy. 2005, Pubmed
The Diabetes Control and Complications Trial Research Group, The effect of intensive diabetes therapy on measures of autonomic nervous system function in the Diabetes Control and Complications Trial (DCCT). 1998, Pubmed
Thomas, Exercise for type 2 diabetes mellitus. 2006, Pubmed
Tobias, Effect of low-fat diet interventions versus other diet interventions on long-term weight change in adults: a systematic review and meta-analysis. 2015, Pubmed
Tonoli, Effects of different types of acute and chronic (training) exercise on glycaemic control in type 1 diabetes mellitus: a meta-analysis. 2012, Pubmed
Toth, The impact of serum lipids on risk for microangiopathy in patients with type 2 diabetes mellitus. 2012, Pubmed
Trento, Rethink Organization to iMprove Education and Outcomes (ROMEO): a multicenter randomized trial of lifestyle intervention by group care to manage type 2 diabetes. 2010, Pubmed
Tuomilehto, Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. 2001, Pubmed
Turner, Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23). 1998, Pubmed
UK Prospective Diabetes Study Group, Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. 1998, Pubmed
UK Prospective Diabetes Study Group, Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. UK Prospective Diabetes Study Group. 1998, Pubmed
Ueki, Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial. 2017, Pubmed
Umemura, The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019). 2019, Pubmed
Umpierre, Physical activity advice only or structured exercise training and association with HbA1c levels in type 2 diabetes: a systematic review and meta-analysis. 2011, Pubmed
Urakami, Urine glucose screening program at schools in Japan to detect children with diabetes and its outcome-incidence and clinical characteristics of childhood type 2 diabetes in Japan. 2007, Pubmed
Urakami, Screening and treatment of childhood type 1 and type 2 diabetes mellitus in Japan. 2012, Pubmed
Vamos, Effectiveness of the influenza vaccine in preventing admission to hospital and death in people with type 2 diabetes. 2016, Pubmed
Van Gaal, Miglitol combined with metformin improves glycaemic control in type 2 diabetes. 2001, Pubmed
Vancampfort, Type 2 Diabetes Among People With Posttraumatic Stress Disorder: Systematic Review and Meta-Analysis. 2016, Pubmed
Vestergaard, Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes--a meta-analysis. 2007, Pubmed
Vetter, Night Shift Work, Genetic Risk, and Type 2 Diabetes in the UK Biobank. 2018, Pubmed
Vetter, Mismatch of Sleep and Work Timing and Risk of Type 2 Diabetes. 2015, Pubmed
Vilsbøll, Efficacy and safety of sitagliptin when added to insulin therapy in patients with type 2 diabetes. 2010, Pubmed
Wang, Plasma fatty acid composition and incidence of diabetes in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. 2003, Pubmed
Wang, Effects of RAS inhibitors on diabetic retinopathy: a systematic review and meta-analysis. 2015, Pubmed
Wang, Impact of low-density lipoprotein cholesterol on cardiovascular outcomes in people with type 2 diabetes: a meta-analysis of prospective cohort studies. 2013, Pubmed
Weber, Type 1 diabetes is associated with an increased risk of fracture across the life span: a population-based cohort study using The Health Improvement Network (THIN). 2015, Pubmed
Weck, Structured health care for subjects with diabetic foot ulcers results in a reduction of major amputation rates. 2013, Pubmed
Whelton, Clinical outcomes in antihypertensive treatment of type 2 diabetes, impaired fasting glucose concentration, and normoglycemia: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). 2005, Pubmed
White, Alogliptin after acute coronary syndrome in patients with type 2 diabetes. 2013, Pubmed
White, Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT). 2001, Pubmed
Wilding, Efficacy and safety of canagliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin and sulphonylurea: a randomised trial. 2013, Pubmed
Wing, Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. 2013, Pubmed
Wing, Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial. 2010, Pubmed
Winkley, Psychological interventions to improve glycaemic control in patients with type 1 diabetes: systematic review and meta-analysis of randomised controlled trials. 2006, Pubmed
Wolfsdorf, ISPAD Clinical Practice Consensus Guidelines 2014. Diabetic ketoacidosis and hyperglycemic hyperosmolar state. 2014, Pubmed
Wright, Sulfonylurea inadequacy: efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the U.K. Prospective Diabetes Study (UKPDS 57). 2002, Pubmed
Xu, Workplace bullying and violence as risk factors for type 2 diabetes: a multicohort study and meta-analysis. 2018, Pubmed
Yamada, Effect of combination therapy of a rapid-acting insulin secretagogue (glinide) with premixed insulin in type 2 diabetes mellitus. 2007, Pubmed
Yamashita, Effects of valsartan versus amlodipine in diabetic hypertensive patients with or without previous cardiovascular disease. 2013, Pubmed
Yan, Roux-en-Y Gastric Bypass Versus Medical Treatment for Type 2 Diabetes Mellitus in Obese Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. 2016, Pubmed
Yang, Tea consumption and risk of type 2 diabetes: a dose-response meta-analysis of cohort studies. 2014, Pubmed
Yao, Dietary fiber intake and risk of type 2 diabetes: a dose-response analysis of prospective studies. 2014, Pubmed
Yardley, A systematic review and meta-analysis of exercise interventions in adults with type 1 diabetes. 2014, Pubmed
Yasuda, Superiority of duloxetine to placebo in improving diabetic neuropathic pain: Results of a randomized controlled trial in Japan. 2011, Pubmed
Yki-Järvinen, Comparison of bedtime insulin regimens in patients with type 2 diabetes mellitus. A randomized, controlled trial. 1999, Pubmed
Younis, Incidence of sight-threatening retinopathy in patients with type 2 diabetes in the Liverpool Diabetic Eye Study: a cohort study. 2003, Pubmed
Yui, Nifedipine retard was as effective as angiotensin converting enzyme inhibitors in preventing cardiac events in high-risk hypertensive patients with diabetes and coronary artery disease: the Japan Multicenter Investigation for Cardiovascular Diseases-B (JMIC-B) subgroup analysis. 2004, Pubmed
Zeitler, ISPAD Clinical Practice Consensus Guidelines 2014. Type 2 diabetes in the child and adolescent. 2014, Pubmed
Zhang, Effect of lifestyle interventions on cardiovascular risk factors among adults without impaired glucose tolerance or diabetes: A systematic review and meta-analysis. 2017, Pubmed
Zhang, Combinational therapy with metformin and sodium-glucose cotransporter inhibitors in management of type 2 diabetes: systematic review and meta-analyses. 2014, Pubmed
Ziegler, Frequency of SMBG correlates with HbA1c and acute complications in children and adolescents with type 1 diabetes. 2011, Pubmed
Zinman, Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes. 2015, Pubmed
Zoungas, Effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomised controlled trials. 2017, Pubmed
de Luis, Effect of repaglinide addition to NPH insulin monotherapy on glycemic control in patients with type 2 diabetes. 2001, Pubmed
de Veciana, Postprandial versus preprandial blood glucose monitoring in women with gestational diabetes mellitus requiring insulin therapy. 1995, Pubmed
de Vries, Primary prevention of major cardiovascular and cerebrovascular events with statins in diabetic patients: a meta-analysis. 2012, Pubmed
de Vries, Efficacy of standard and intensive statin treatment for the secondary prevention of cardiovascular and cerebrovascular events in diabetes patients: a meta-analysis. 2014, Pubmed
le Roux, 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial. 2017, Pubmed
van Dam, Coffee consumption and risk of type 2 diabetes: a systematic review. 2005, Pubmed
van Netten, Prevention of foot ulcers in the at-risk patient with diabetes: a systematic review. 2016, Pubmed
van de Poll-Franse, Less aggressive treatment and worse overall survival in cancer patients with diabetes: a large population based analysis. 2007, Pubmed